159 related articles for article (PubMed ID: 30085893)
21. Is It Relevant to Keep Advocating Visual Inspection of the Cervix With Acetic Acid for Primary Cervical Cancer Screening in Limited-Resource Settings?
Fokom Domgue J; Valea FA
J Glob Oncol; 2018 Sep; 4():1-5. PubMed ID: 30241142
[No Abstract] [Full Text] [Related]
22. Screening for cervical cancer in low-resource settings in 2011.
Tambouret R
Arch Pathol Lab Med; 2013 Jun; 137(6):782-90. PubMed ID: 23721273
[TBL] [Abstract][Full Text] [Related]
23. Socio demographic and reproductive risk factors for cervical cancer - a large prospective cohort study from rural India.
Thulaseedharan JV; Malila N; Hakama M; Esmy PO; Cheriyan M; Swaminathan R; Muwonge R; Sankaranarayanan R
Asian Pac J Cancer Prev; 2012; 13(6):2991-5. PubMed ID: 22938495
[TBL] [Abstract][Full Text] [Related]
24. Advances in technologies for cervical cancer detection in low-resource settings.
Kundrod KA; Smith CA; Hunt B; Schwarz RA; Schmeler K; Richards-Kortum R
Expert Rev Mol Diagn; 2019 Aug; 19(8):695-714. PubMed ID: 31368827
[No Abstract] [Full Text] [Related]
25. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities.
Wright TC; Cox JT; Massad LS; Twiggs LB; Wilkinson EJ;
JAMA; 2002 Apr; 287(16):2120-9. PubMed ID: 11966387
[TBL] [Abstract][Full Text] [Related]
26. [Global guidelines for cervical cancer and precancerous lesions treatment: a systematic review].
Zhao S; Chen H; Zhao FH
Zhonghua Yi Xue Za Zhi; 2022 Jun; 102(22):1666-1676. PubMed ID: 35692019
[No Abstract] [Full Text] [Related]
27. Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories.
Nayar R; Chhieng DC; Crothers B; Darragh TM; Davey DD; Eisenhut C; Goulart R; Huang EC; Tabbara SO
J Am Soc Cytopathol; 2020; 9(4):291-303. PubMed ID: 32565297
[TBL] [Abstract][Full Text] [Related]
28. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
29. Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries.
Campos NG; Sharma M; Clark A; Kim JJ; Resch SC
PLoS One; 2016; 11(10):e0164000. PubMed ID: 27711124
[TBL] [Abstract][Full Text] [Related]
30. The investment case for cervical cancer elimination.
Tsu VD; Ginsburg O
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():69-73. PubMed ID: 28691328
[TBL] [Abstract][Full Text] [Related]
31. Contribution of Tata Memorial Centre, India, to cervical cancer care: Journey of two decades.
Kumar A; Chopra S; Gupta S
Indian J Med Res; 2021 Aug; 154(2):319-328. PubMed ID: 35295006
[TBL] [Abstract][Full Text] [Related]
32. Cervical cancer in Tosamaganga Hospital, Tanzania: difficulties and challenges in a low resource country setting.
Cola E; Maziku D; Torelli GF; Fagotti A
Int J Gynecol Cancer; 2019 Oct; 29(8):1336-1337. PubMed ID: 31326948
[No Abstract] [Full Text] [Related]
33. Delivering cervical cancer prevention services in low-resource settings.
Bradley J; Barone M; Mahé C; Lewis R; Luciani S
Int J Gynaecol Obstet; 2005 May; 89 Suppl 2():S21-9. PubMed ID: 15823263
[TBL] [Abstract][Full Text] [Related]
34. Establishing Baseline Cervical Cancer Screening Coverage - India, 2015-2016.
Van Dyne EA; Hallowell BD; Saraiya M; Senkomago V; Patel SA; Agrawal S; Ghosh A; Saraf D; Mehrotra R; Dhillon PK
MMWR Morb Mortal Wkly Rep; 2019 Jan; 68(1):14-19. PubMed ID: 30629571
[TBL] [Abstract][Full Text] [Related]
35. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia.
Wright TC; Cox JT; Massad LS; Carlson J; Twiggs LB; Wilkinson EJ;
Am J Obstet Gynecol; 2003 Jul; 189(1):295-304. PubMed ID: 12861176
[TBL] [Abstract][Full Text] [Related]
36. Community cancer screening at primary care level in Northern India: determinants and policy implications for cancer prevention.
Sharma P; Khanna D; Pradhan S; Birur P
Fam Med Community Health; 2023 Dec; 11(Suppl 1):. PubMed ID: 38105243
[TBL] [Abstract][Full Text] [Related]
37. Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Guideline Update.
Shastri SS; Temin S; Almonte M; Basu P; Campos NG; Gravitt PE; Gupta V; Lombe DC; Murillo R; Nakisige C; Ogilvie G; Pinder LF; Poli UR; Qiao Y; Woo YL; Jeronimo J
JCO Glob Oncol; 2022 Sep; 8():e2200217. PubMed ID: 36162041
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the Performance of Hybrid Capture 2 Test as a Primary Screening Test from Studies Conducted in Low and Middle-Income Country Settings- Special Focus India.
Anand KV; Pimple SA; Bhattacharjee A; Mishra GA; Shastri SS
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2709-2716. PubMed ID: 34452578
[TBL] [Abstract][Full Text] [Related]
39. Cervical cancer screening status and implementation challenges: Report from selected states of India.
Dsouza JP; Van den Broucke S; Pattanshetty S; Dhoore W
Int J Health Plann Manage; 2022 Mar; 37(2):824-838. PubMed ID: 34716616
[TBL] [Abstract][Full Text] [Related]
40. A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
Vadaparampil ST; Fuzzell LN; Brownstein NC; Fontenot HB; Lake P; Michel A; McIntyre M; Whitmer A; Perkins RB
Cancer; 2023 Sep; 129(17):2671-2684. PubMed ID: 37221653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
